×

System and method for evaluating and comparing medical treatments

  • US 8,719,051 B2
  • Filed: 10/31/2011
  • Issued: 05/06/2014
  • Est. Priority Date: 01/13/2011
  • Status: Expired due to Fees
First Claim
Patent Images

1. A computer-implemented method for evaluating a drug, biologic or medical device in research and development, the method comprising:

  • using a computerized processor for;

    defining a maximum benefit numerical score representing total benefits of a drug, biologic or medical device based on clinical trial data;

    defining a maximum risk numerical score representing total risks of the drug, biologic or medical device based on clinical trial data;

    receiving identification of a plurality of model categories, wherein the model categories are selected from;

    a plurality of medical efficacy and safety categories;

    a plurality of value proposition categories; and

    a plurality of market dynamics categories;

    receiving scaled adjustment values associated with the identified model categories, wherein the scaled adjustment values represent importance of factor elements within a model category;

    apportioning the maximum benefit numerical score among the identified model categories based on the scaled adjustment values associated with the model categories;

    apportioning the maximum risk numerical score among the identified model categories based on the scaled adjustment values associated with the model categories;

    receiving an identification of one or more factor elements defined within one or more of the model categories;

    receiving a plurality of risk scores and benefit scores for the identified factor elements;

    generating an overall numerical benefit score based on the aggregate of the benefit scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories;

    generating an overall numerical risk score based on the aggregate of the risk scores for the identified factor elements as adjusted by the scaled adjustment values associated with the model categories;

    storing the overall numerical risk and overall numerical benefit scores for the drug, biologic or medical device as separate benefit and risk values in a computerized storage device; and

    displaying the stored overall scores on one or more axes.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×